Who
Todd Shegog
Director
Company insider
Files Form 4 as: Director, Cogent Biosciences; SVP, Chief Financial Officer, Forma Therapeutics Holdings; Officer, Synlogic.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $56K
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 14 Mar 2018
- Last trade
- 9 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 11 Jun 2026 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,901 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,901 at $0.00 | filing |
| 4 Jun 2025filed 5 Jun 2025 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,700 at $0.00 | filing |
| 5 Jun 2024filed 13 Jun 2024 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,700 at $0.00 | filing |
| 7 Jun 2023filed 8 Jun 2023 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,700 at $0.00 | filing |
| 14 Oct 2022filed 14 Oct 2022 | Forma Therapeutics Holdingsoption or derivative | SEC FORM 4 Code D | —153,528 | filing |
| 14 Oct 2022filed 14 Oct 2022 | Forma Therapeutics Holdingsoption or derivative | SEC FORM 4 Code D | —11,689 | filing |
| 14 Oct 2022filed 14 Oct 2022 | Forma Therapeutics Holdingsoption or derivative | SEC FORM 4 Code D | —116,890 | filing |
| 14 Oct 2022filed 14 Oct 2022 | Forma Therapeutics Holdingsoption or derivative | SEC FORM 4 Code D | —70,134 | filing |
| 14 Oct 2022filed 14 Oct 2022 | Forma Therapeutics Holdingsoption or derivative | SEC FORM 4 Code D | —50,250 | filing |
| 14 Oct 2022filed 14 Oct 2022 | Forma Therapeutics Holdingsoption or derivative | SEC FORM 4 Code D | —50,000 | filing |
| 14 Oct 2022filed 14 Oct 2022 | Forma Therapeutics Holdings | SEC FORM 4 Code U | —56,143 | filing |
| 7 Jun 2022filed 9 Jun 2022 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,700 at $0.00 | filing |
| 28 Feb 2022filed 2 Mar 2022 | Forma Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 28 Feb 2022filed 2 Mar 2022 | Forma Therapeutics Holdings | SEC FORM 4 Code A | —33,330 at $0.00 | filing |
| 23 Feb 2022filed 25 Feb 2022 | Forma Therapeutics Holdings | SEC FORM 4 Sold | $56K5,687 at $9.78 | filing |
| 11 Mar 2021filed 15 Mar 2021 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 26 Feb 2021filed 2 Mar 2021 | Forma Therapeutics Holdings | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 26 Feb 2021filed 2 Mar 2021 | Forma Therapeutics Holdings | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 26 Feb 2021filed 2 Mar 2021 | Forma Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —50,250 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.